UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION

Inhibitors of the renin-angiotensin-aldosterone system, statins, and possibly , ω-3 polyunsaturated fatty acids may influence the incidence of atrial fibrillation (AF), and can be used to prevent it. In recent medical literature, this approach is referred to as upstream treatment. The results of exp...

Full description

Bibliographic Details
Main Authors: E. A. Protasova, N. V. Furman, O. V. Reshet'ko
Format: Article
Language:English
Published: Столичная издательская компания 2015-12-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/501
_version_ 1797232389312741376
author E. A. Protasova
N. V. Furman
O. V. Reshet'ko
author_facet E. A. Protasova
N. V. Furman
O. V. Reshet'ko
author_sort E. A. Protasova
collection DOAJ
description Inhibitors of the renin-angiotensin-aldosterone system, statins, and possibly , ω-3 polyunsaturated fatty acids may influence the incidence of atrial fibrillation (AF), and can be used to prevent it. In recent medical literature, this approach is referred to as upstream treatment. The results of experiments and clinical studies show that the use of these drugs may be useful for AF primary prevention in certain categories of patients. Nevertheless, there are currently no sufficient evidences to justify these recommendations and apply them to a wider range of patients with AF risk factors. Thus, it is reasonable to continue studies on both primary and secondary AF prevention.
first_indexed 2024-03-08T14:05:10Z
format Article
id doaj.art-9a0b4791df1047b89b50143fd1349df3
institution Directory Open Access Journal
issn 1819-6446
2225-3653
language English
last_indexed 2024-04-24T15:59:30Z
publishDate 2015-12-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj.art-9a0b4791df1047b89b50143fd1349df32024-04-01T07:43:25ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-12-018456156810.20996/1819-6446-2012-8-4-561-568501UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTIONE. A. Protasova0N. V. Furman1O. V. Reshet'ko2Saratov Research Institute for CardiologySaratov Research Institute for CardiologySaratov State Medical University named after V.I. RazumovskyInhibitors of the renin-angiotensin-aldosterone system, statins, and possibly , ω-3 polyunsaturated fatty acids may influence the incidence of atrial fibrillation (AF), and can be used to prevent it. In recent medical literature, this approach is referred to as upstream treatment. The results of experiments and clinical studies show that the use of these drugs may be useful for AF primary prevention in certain categories of patients. Nevertheless, there are currently no sufficient evidences to justify these recommendations and apply them to a wider range of patients with AF risk factors. Thus, it is reasonable to continue studies on both primary and secondary AF prevention.https://www.rpcardio.online/jour/article/view/501atrial fibrillationprevention
spellingShingle E. A. Protasova
N. V. Furman
O. V. Reshet'ko
UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION
Рациональная фармакотерапия в кардиологии
atrial fibrillation
prevention
title UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION
title_full UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION
title_fullStr UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION
title_full_unstemmed UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION
title_short UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION
title_sort up to day possibilities of atrial fibrillation prevention
topic atrial fibrillation
prevention
url https://www.rpcardio.online/jour/article/view/501
work_keys_str_mv AT eaprotasova uptodaypossibilitiesofatrialfibrillationprevention
AT nvfurman uptodaypossibilitiesofatrialfibrillationprevention
AT ovreshetko uptodaypossibilitiesofatrialfibrillationprevention